Mast Cell Activation and KSHV Infection in Kaposi Sarcoma
Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on sustained proinflammatory signals provided by intralesional leukocytes and continued infection of new ECs. However, the sources of these cytokines and i...
Saved in:
Published in | Clinical cancer research Vol. 24; no. 20; pp. 5085 - 5097 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
15.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on sustained proinflammatory signals provided by intralesional leukocytes and continued infection of new ECs. However, the sources of these cytokines and infectious virus within lesions are not fully understood. Here, mast cells (MCs) are identified as proinflammatory cells within KS lesions that are permissive for, and activated by, infection with KSHV.
Three validated MC lines were used to assess permissivity of MCs to infection with KSHV and to evaluate MCs activation following infection. Biopsies from 31 AIDS-KS cases and 11 AIDS controls were evaluated by IHC for the presence of MCs in KS lesions and assessment of MC activation state and infection with KSHV. Plasma samples from 26 AIDS-KS, 13 classic KS, and 13 healthy adults were evaluated for levels of MC granule contents tryptase and histamine.
In culture, MCs supported latent and lytic KSHV infection, and infection-induced MC degranulation. Within KS lesions, MCs were closely associated with spindle cells. Furthermore, MC activation was extensive within patients with KS, reflected by elevated circulating levels of tryptase and a histamine metabolite. One patient with clinical signs of extensive MC activation was treated with antagonists of MC proinflammatory mediators, which resulted in a rapid and durable regression of AIDS-KS lesions.
Using complimentary
and
studies we identify MCs as a potential long-lived reservoir for KSHV and a source of proinflammatory mediators within the KS lesional microenvironment. In addition, we identify MC antagonists as a promising novel therapeutic approach for KS.
. |
---|---|
AbstractList | Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on sustained proinflammatory signals provided by intralesional leukocytes and continued infection of new ECs. However, the sources of these cytokines and infectious virus within lesions are not fully understood. Here, mast cells (MCs) are identified as proinflammatory cells within KS lesions that are permissive for, and activated by, infection with KSHV.
Three validated MC lines were used to assess permissivity of MCs to infection with KSHV and to evaluate MCs activation following infection. Biopsies from 31 AIDS-KS cases and 11 AIDS controls were evaluated by IHC for the presence of MCs in KS lesions and assessment of MC activation state and infection with KSHV. Plasma samples from 26 AIDS-KS, 13 classic KS, and 13 healthy adults were evaluated for levels of MC granule contents tryptase and histamine.
In culture, MCs supported latent and lytic KSHV infection, and infection-induced MC degranulation. Within KS lesions, MCs were closely associated with spindle cells. Furthermore, MC activation was extensive within patients with KS, reflected by elevated circulating levels of tryptase and a histamine metabolite. One patient with clinical signs of extensive MC activation was treated with antagonists of MC proinflammatory mediators, which resulted in a rapid and durable regression of AIDS-KS lesions.
Using complimentary
and
studies we identify MCs as a potential long-lived reservoir for KSHV and a source of proinflammatory mediators within the KS lesional microenvironment. In addition, we identify MC antagonists as a promising novel therapeutic approach for KS.
. Abstract Purpose: Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS–associated herpesvirus (KSHV). KS is dependent on sustained proinflammatory signals provided by intralesional leukocytes and continued infection of new ECs. However, the sources of these cytokines and infectious virus within lesions are not fully understood. Here, mast cells (MCs) are identified as proinflammatory cells within KS lesions that are permissive for, and activated by, infection with KSHV. Experimental Design: Three validated MC lines were used to assess permissivity of MCs to infection with KSHV and to evaluate MCs activation following infection. Biopsies from 31 AIDS-KS cases and 11 AIDS controls were evaluated by IHC for the presence of MCs in KS lesions and assessment of MC activation state and infection with KSHV. Plasma samples from 26 AIDS-KS, 13 classic KS, and 13 healthy adults were evaluated for levels of MC granule contents tryptase and histamine. Results: In culture, MCs supported latent and lytic KSHV infection, and infection-induced MC degranulation. Within KS lesions, MCs were closely associated with spindle cells. Furthermore, MC activation was extensive within patients with KS, reflected by elevated circulating levels of tryptase and a histamine metabolite. One patient with clinical signs of extensive MC activation was treated with antagonists of MC proinflammatory mediators, which resulted in a rapid and durable regression of AIDS-KS lesions. Conclusions: Using complimentary in vitro and in vivo studies we identify MCs as a potential long-lived reservoir for KSHV and a source of proinflammatory mediators within the KS lesional microenvironment. In addition, we identify MC antagonists as a promising novel therapeutic approach for KS. Clin Cancer Res; 24(20); 5085–97. ©2018 AACR. Purpose: Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on sustained proinflammatory signals provided by intralesional leukocytes and continued infection of new ECs. However, the sources of these cytokines and infectious virus within lesions are not fully understood. Here, mast cells (MCs) are identified as proinflammatory cells within KS lesions that are permissive for, and activated by, infection with KSHV.Experimental Design: Three validated MC lines were used to assess permissivity of MCs to infection with KSHV and to evaluate MCs activation following infection. Biopsies from 31 AIDS-KS cases and 11 AIDS controls were evaluated by IHC for the presence of MCs in KS lesions and assessment of MC activation state and infection with KSHV. Plasma samples from 26 AIDS-KS, 13 classic KS, and 13 healthy adults were evaluated for levels of MC granule contents tryptase and histamine.Results: In culture, MCs supported latent and lytic KSHV infection, and infection-induced MC degranulation. Within KS lesions, MCs were closely associated with spindle cells. Furthermore, MC activation was extensive within patients with KS, reflected by elevated circulating levels of tryptase and a histamine metabolite. One patient with clinical signs of extensive MC activation was treated with antagonists of MC proinflammatory mediators, which resulted in a rapid and durable regression of AIDS-KS lesions.Conclusions: Using complimentary in vitro and in vivo studies we identify MCs as a potential long-lived reservoir for KSHV and a source of proinflammatory mediators within the KS lesional microenvironment. In addition, we identify MC antagonists as a promising novel therapeutic approach for KS. Clin Cancer Res; 24(20); 5085-97. ©2018 AACR. |
Author | Cesarman, Ethel McAllister, Shane C Wang, Dongliang Barbachano-Guerrero, Arturo Bartlett, Linda C Rochford, Rosemary Martin, Jeffrey N Asiago-Reddy, Elizabeth Ritchie, Julie A Ayers, Leona W King, Christine A |
AuthorAffiliation | 1 Department of Pathology, The Ohio State University, Columbus, Ohio 4 Department of Medicine, SUNY Upstate Medical University, Syracuse, NY 3 Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN 6 Department of Public Health and Preventative Medicine, SUNY Upstate Medical University, Syracuse, NY 7 Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 2 Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY 5 Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY |
AuthorAffiliation_xml | – name: 1 Department of Pathology, The Ohio State University, Columbus, Ohio – name: 5 Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY – name: 7 Department of Epidemiology and Biostatistics, University of California, San Francisco, CA – name: 4 Department of Medicine, SUNY Upstate Medical University, Syracuse, NY – name: 2 Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY – name: 3 Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN – name: 6 Department of Public Health and Preventative Medicine, SUNY Upstate Medical University, Syracuse, NY |
Author_xml | – sequence: 1 givenname: Leona W surname: Ayers fullname: Ayers, Leona W organization: Department of Pathology, The Ohio State University, Columbus, Ohio – sequence: 2 givenname: Arturo surname: Barbachano-Guerrero fullname: Barbachano-Guerrero, Arturo organization: Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York – sequence: 3 givenname: Shane C surname: McAllister fullname: McAllister, Shane C organization: Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota – sequence: 4 givenname: Julie A surname: Ritchie fullname: Ritchie, Julie A organization: Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York – sequence: 5 givenname: Elizabeth surname: Asiago-Reddy fullname: Asiago-Reddy, Elizabeth organization: Department of Medicine, SUNY Upstate Medical University, Syracuse, New York – sequence: 6 givenname: Linda C surname: Bartlett fullname: Bartlett, Linda C organization: Department of Medicine, SUNY Upstate Medical University, Syracuse, New York – sequence: 7 givenname: Ethel surname: Cesarman fullname: Cesarman, Ethel organization: Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York – sequence: 8 givenname: Dongliang surname: Wang fullname: Wang, Dongliang organization: Department of Public Health and Preventative Medicine, SUNY Upstate Medical University, Syracuse, New York – sequence: 9 givenname: Rosemary surname: Rochford fullname: Rochford, Rosemary organization: Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York – sequence: 10 givenname: Jeffrey N surname: Martin fullname: Martin, Jeffrey N organization: Department of Epidemiology and Biostatistics, University of California, San Francisco, California – sequence: 11 givenname: Christine A surname: King fullname: King, Christine A email: kingch@upstate.edu organization: Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York. kingch@upstate.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30084838$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkMtOwzAQRS1UBG3hE0BZsknx-BVng1RFQKuCkCiwtRzHhaDWLnFaib_HpQ_Bxr7y3LnjOT3Ucd5ZhC4ADwC4vAacyRQzSgZF8ZxC1DKjR6gLnGcpJYJ3ot57TlEvhE-MgQFmJ-iUYiyZpLKL8kcd2qSw83kyNG291m3tXaJdlUymo7dk7GbW_D7VLpnopQ91MtWN8Qt9ho5neh7s-e7uo9e725dilD483Y-L4UNqGECbMppXFWipOePZTEIprNZlPDGpGBhgAleVJMRwXuaEMSFIlklBcCZIycqM9tHNNne5Khe2Mta1jZ6rZVMvdPOtvK7V_4qrP9S7XysBOVCOY8DVLqDxXysbWrWog4kba2f9KigSWURnLvJo5VuraXwIjZ0dxgBWG-xqg1RtkKqIXUHUEXvsu_z7x0PXnjP9AXjDfm4 |
CitedBy_id | crossref_primary_10_1371_journal_ppat_1008156 crossref_primary_10_1136_bcr_2020_235204 crossref_primary_10_1007_s13555_021_00524_w crossref_primary_10_1155_2020_8852221 crossref_primary_10_1186_s12981_023_00558_4 crossref_primary_10_3390_v15041011 crossref_primary_10_1093_infdis_jiaa340 crossref_primary_10_3390_diagnostics12051242 crossref_primary_10_1128_JVI_01692_19 crossref_primary_10_1177_0300060519895347 crossref_primary_10_1016_j_jmgm_2023_108539 crossref_primary_10_3389_fcimb_2021_603309 crossref_primary_10_1111_ijd_15895 |
Cites_doi | 10.1371/journal.pntd.0001505 10.1046/j.1523-1747.1998.00359.x 10.1128/JVI.78.8.4207-4223.2004 10.1067/mai.2001.111930 10.1111/j.1365-2222.2011.03848.x 10.1186/1756-8722-4-10 10.1016/j.it.2007.03.003 10.1038/leu.2012.81 10.4049/jimmunol.165.1.211 10.1038/sj.leu.2403992 10.1016/j.ccr.2007.01.015 10.1002/jlb.49.2.197 10.1126/science.1120878 10.1128/JVI.01630-10 10.1084/jem.20042407 10.1038/cmi.2014.73 10.1172/JCI79840 10.1073/pnas.91.26.12755 10.1128/JVI.74.15.7146-7150.2000 10.1016/S0090-4295(01)01258-4 10.1182/blood-2003-11-3816 10.1128/JVI.02976-12 10.1182/blood-2011-07-358432 10.1128/JVI.76.16.8408-8419.2002 10.4049/jimmunol.123.4.1445 10.1371/journal.ppat.1000777 10.1146/annurev.pathol.1.110304.100133 10.5858/arpa.2011-0325-RS 10.1006/viro.1996.8303 10.1016/j.virol.2009.05.011 10.1073/pnas.1716804115 10.1128/JVI.01587-07 10.1111/j.1600-065X.2007.00520.x 10.4049/jimmunol.1202096 10.1016/S0091-6749(87)80276-2 10.1097/00129039-200506000-00009 10.1200/JCO.2005.06.079 10.1189/jlb.0405226 10.1056/NEJM198706253162603 10.1007/978-1-4684-4163-5 10.1111/j.1346-8138.1999.tb02052.x 10.1182/blood-2003-02-0641 10.1182/blood-2012-03-415638 10.1016/S0092-8674(02)00628-1 10.1016/j.jaci.2013.02.011 10.1016/S1471-4906(01)02050-6 10.1128/JVI.01769-06 10.1172/JCI200417803 10.1172/JCI27249 10.1016/j.anndiagpath.2016.06.003 10.1038/ni1158 10.1128/JVI.76.16.8383-8399.2002 10.1159/000236928 10.1128/JVI.78.7.3601-3620.2004 |
ContentType | Journal Article |
Copyright | 2018 American Association for Cancer Research. |
Copyright_xml | – notice: 2018 American Association for Cancer Research. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1158/1078-0432.CCR-18-0873 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1557-3265 |
EndPage | 5097 |
ExternalDocumentID | 10_1158_1078_0432_CCR_18_0873 30084838 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA119903 – fundername: NCI NIH HHS grantid: UM1 CA181255 – fundername: NIAID NIH HHS grantid: R03 AI122221 – fundername: NCI NIH HHS grantid: R01 CA102667 – fundername: NCI NIH HHS grantid: U54 CA190153 – fundername: NIAID NIH HHS grantid: P30 AI027763 |
GroupedDBID | --- 18M 29B 2FS 2WC 34G 39C 476 53G 5GY 5RE 5VS 6J9 ABOCM ACGFO ACIWK ACPRK ACSVP ADBBV ADCOW ADNWM AENEX AFHIN AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BR6 BTFSW CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 IH2 KQ8 L7B LSO NPM OK1 P0W P2P QTD RCR RHF RHI RNS SJN TR2 W2D W8F WOQ YKV AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c411t-439dd1a8a5457f81b6eaabb6e02d41c1460dd822c55b9244662778620762b4b73 |
ISSN | 1078-0432 |
IngestDate | Tue Sep 17 21:14:38 EDT 2024 Sat Oct 26 05:00:26 EDT 2024 Fri Aug 23 02:11:37 EDT 2024 Sat Nov 02 12:16:31 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 20 |
Language | English |
License | 2018 American Association for Cancer Research. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c411t-439dd1a8a5457f81b6eaabb6e02d41c1460dd822c55b9244662778620762b4b73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 current address: Department of Immunology and Microbiology, University of Colorado, Denver, Aurora, CO. |
OpenAccessLink | https://clincancerres.aacrjournals.org/content/clincanres/24/20/5085.full.pdf |
PMID | 30084838 |
PQID | 2084913969 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6191350 proquest_miscellaneous_2084913969 crossref_primary_10_1158_1078_0432_CCR_18_0873 pubmed_primary_30084838 |
PublicationCentury | 2000 |
PublicationDate | 2018-10-15 |
PublicationDateYYYYMMDD | 2018-10-15 |
PublicationDate_xml | – month: 10 year: 2018 text: 2018-10-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Clinical cancer research |
PublicationTitleAlternate | Clin Cancer Res |
PublicationYear | 2018 |
References | Tachimoto (2022061107215311500_bib37) 2001; 107 Metz (2022061107215311500_bib7) 2007; 217 Roizman (2022061107215311500_bib27) 1982 Nakayama (2022061107215311500_bib44) 2006; 79 Zhang (2022061107215311500_bib50) 1994; 91 Ghannadan (2022061107215311500_bib38) 1998; 111 King (2022061107215311500_bib21) 2013; 87 Graham (2022061107215311500_bib12) 2013; 190 Molderings (2022061107215311500_bib31) 2011; 4 King (2022061107215311500_bib10) 2002; 76 Stoecker (2022061107215311500_bib14) 2012; 136 Kaleeba (2022061107215311500_bib40) 2006; 311 King (2022061107215311500_bib11) 2000; 74 Sheng-Hsuan Chien (2022061107215311500_bib20) 2016 Mutlu (2022061107215311500_bib26) 2007; 11 Saadalla (2022061107215311500_bib15) 2018; 115 Yang (2022061107215311500_bib32) 2016; 24 Schwartz (2022061107215311500_bib25) 1979; 123 Theoharides (2022061107215311500_bib28) 2001; 58 Galli (2022061107215311500_bib5) 2005; 6 Maltby (2022061107215311500_bib13) 2009; 1796 Akin (2022061107215311500_bib52) 2004; 103 Grundhoff (2022061107215311500_bib2) 2004; 113 Becker (2022061107215311500_bib36) 2015; 12 Maaninka (2022061107215311500_bib4) 2013; 132 Brown (2022061107215311500_bib9) 2011; 85 Yao (2022061107215311500_bib41) 2003; 102 Hagiwara (2022061107215311500_bib3) 1999; 26 Parsons (2022061107215311500_bib22) 2006; 116 Ganem (2022061107215311500_bib1) 2006; 1 Krishnan (2022061107215311500_bib34) 2004; 78 Sharma-Walia (2022061107215311500_bib33) 2004; 78 Giannou (2022061107215311500_bib16) 2015; 125 Glimelius (2022061107215311500_bib18) 2005; 19 Akula (2022061107215311500_bib39) 2002; 108 Lin (2022061107215311500_bib42) 2000; 165 Dvorak (2022061107215311500_bib53) 1991; 49 Rappocciolo (2022061107215311500_bib35) 2008; 82 Sharma-Walia (2022061107215311500_bib46) 2010; 6 Rabenhorst (2022061107215311500_bib17) 2012; 120 Galli (2022061107215311500_bib51) 1995; 107 Furuta (2022061107215311500_bib47) 2012; 6 Mizuno (2022061107215311500_bib19) 2012; 26 Schwartz (2022061107215311500_bib29) 1987; 80 Borer-Reinhold (2022061107215311500_bib30) 2011; 41 Punjabi (2022061107215311500_bib23) 2007; 81 Falus (2022061107215311500_bib49) 2001; 22 Kunder (2022061107215311500_bib8) 2011; 118 Koon (2022061107215311500_bib56) 2005; 23 Moses (2022061107215311500_bib43) 2002; 76 Schwartz (2022061107215311500_bib48) 1987; 316 Pantanowitz (2022061107215311500_bib55) 2005; 13 Douglas (2022061107215311500_bib54) 2009; 390 Metz (2022061107215311500_bib6) 2007; 28 Pollock (2022061107215311500_bib24) 1997; 227 Weller (2022061107215311500_bib45) 2005; 201 |
References_xml | – volume: 6 start-page: e1505 year: 2012 ident: 2022061107215311500_bib47 article-title: Association of mast cell-derived VEGF and proteases in Dengue shock syndrome publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0001505 contributor: fullname: Furuta – volume: 111 start-page: 689 year: 1998 ident: 2022061107215311500_bib38 article-title: Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.1998.00359.x contributor: fullname: Ghannadan – volume: 78 start-page: 4207 year: 2004 ident: 2022061107215311500_bib33 article-title: Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements publication-title: J Virol doi: 10.1128/JVI.78.8.4207-4223.2004 contributor: fullname: Sharma-Walia – volume: 107 start-page: 302 year: 2001 ident: 2022061107215311500_bib37 article-title: Acquisition and alteration of adhesion molecules during cultured human mast cell differentiation publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2001.111930 contributor: fullname: Tachimoto – volume: 41 start-page: 1777 year: 2011 ident: 2022061107215311500_bib30 article-title: An increase in serum tryptase even below 11.4 ng/mL may indicate a mast cell-mediated hypersensitivity reaction: a prospective study in Hymenoptera venom allergic patients publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.2011.03848.x contributor: fullname: Borer-Reinhold – volume: 4 start-page: 10 year: 2011 ident: 2022061107215311500_bib31 article-title: Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options publication-title: J Hematol Oncol doi: 10.1186/1756-8722-4-10 contributor: fullname: Molderings – volume: 28 start-page: 234 year: 2007 ident: 2022061107215311500_bib6 article-title: Mast cells–key effector cells in immune responses publication-title: Trends Immunol doi: 10.1016/j.it.2007.03.003 contributor: fullname: Metz – volume: 26 start-page: 2269 year: 2012 ident: 2022061107215311500_bib19 article-title: Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib publication-title: Leukemia doi: 10.1038/leu.2012.81 contributor: fullname: Mizuno – volume: 165 start-page: 211 year: 2000 ident: 2022061107215311500_bib42 article-title: Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha publication-title: J Immunol doi: 10.4049/jimmunol.165.1.211 contributor: fullname: Lin – volume: 19 start-page: 2360 year: 2005 ident: 2022061107215311500_bib18 article-title: Angiogenesis and mast cells in Hodgkin lymphoma publication-title: Leukemia doi: 10.1038/sj.leu.2403992 contributor: fullname: Glimelius – year: 2016 ident: 2022061107215311500_bib20 article-title: Diffuse large B cell lymphoma coexistence with systemic mastocytosis publication-title: J Cancer Res Pract contributor: fullname: Sheng-Hsuan Chien – volume: 11 start-page: 245 year: 2007 ident: 2022061107215311500_bib26 article-title: In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma publication-title: Cancer Cell doi: 10.1016/j.ccr.2007.01.015 contributor: fullname: Mutlu – volume: 49 start-page: 197 year: 1991 ident: 2022061107215311500_bib53 article-title: Granule changes of human skin mast cells characteristic of piecemeal degranulation and associated with recovery during wound healing in situ publication-title: J Leukoc Biol doi: 10.1002/jlb.49.2.197 contributor: fullname: Dvorak – volume: 311 start-page: 1921 year: 2006 ident: 2022061107215311500_bib40 article-title: Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT publication-title: Science doi: 10.1126/science.1120878 contributor: fullname: Kaleeba – volume: 85 start-page: 1145 year: 2011 ident: 2022061107215311500_bib9 article-title: Dengue virus infection of mast cells triggers endothelial cell activation publication-title: J Virol doi: 10.1128/JVI.01630-10 contributor: fullname: Brown – volume: 201 start-page: 1961 year: 2005 ident: 2022061107215311500_bib45 article-title: Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors publication-title: J Exp Med doi: 10.1084/jem.20042407 contributor: fullname: Weller – volume: 12 start-page: 192 year: 2015 ident: 2022061107215311500_bib36 article-title: Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms publication-title: Cell Mol Immunol doi: 10.1038/cmi.2014.73 contributor: fullname: Becker – volume: 125 start-page: 2317 year: 2015 ident: 2022061107215311500_bib16 article-title: Mast cells mediate malignant pleural effusion formation publication-title: J Clin Invest doi: 10.1172/JCI79840 contributor: fullname: Giannou – volume: 91 start-page: 12755 year: 1994 ident: 2022061107215311500_bib50 article-title: Hematopoietic development of vav-/- mouse embryonic stem cells publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.91.26.12755 contributor: fullname: Zhang – volume: 74 start-page: 7146 year: 2000 ident: 2022061107215311500_bib11 article-title: Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line publication-title: J Virol doi: 10.1128/JVI.74.15.7146-7150.2000 contributor: fullname: King – volume: 58 start-page: 605 year: 2001 ident: 2022061107215311500_bib28 article-title: Massive extracellular tryptase from activated bladder mast cells in interstitial cystitis publication-title: Urology doi: 10.1016/S0090-4295(01)01258-4 contributor: fullname: Theoharides – volume: 103 start-page: 3222 year: 2004 ident: 2022061107215311500_bib52 article-title: A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib publication-title: Blood doi: 10.1182/blood-2003-11-3816 contributor: fullname: Akin – volume: 87 start-page: 8779 year: 2013 ident: 2022061107215311500_bib21 article-title: Kaposi's sarcoma-associated Herpes virus Kaposin B induces unique monophosphorylation of STAT3 at Serine 727 and MK2-mediated inactivation of the STAT3 transcriptional repressor TRIM28 publication-title: J Virol doi: 10.1128/JVI.02976-12 contributor: fullname: King – volume: 118 start-page: 5383 year: 2011 ident: 2022061107215311500_bib8 article-title: Mast cell modulation of the vascular and lymphatic endothelium publication-title: Blood doi: 10.1182/blood-2011-07-358432 contributor: fullname: Kunder – volume: 76 start-page: 8408 year: 2002 ident: 2022061107215311500_bib10 article-title: Dengue virus selectively induces human mast cell chemokine production publication-title: J Virol doi: 10.1128/JVI.76.16.8408-8419.2002 contributor: fullname: King – volume: 123 start-page: 1445 year: 1979 ident: 2022061107215311500_bib25 article-title: Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells publication-title: J Immunol doi: 10.4049/jimmunol.123.4.1445 contributor: fullname: Schwartz – volume: 6 start-page: e1000777 year: 2010 ident: 2022061107215311500_bib46 article-title: Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1000777 contributor: fullname: Sharma-Walia – volume: 1 start-page: 273 year: 2006 ident: 2022061107215311500_bib1 article-title: KSHV infection and the pathogenesis of Kaposi's sarcoma publication-title: Annu Rev Pathol doi: 10.1146/annurev.pathol.1.110304.100133 contributor: fullname: Ganem – volume: 136 start-page: 832 year: 2012 ident: 2022061107215311500_bib14 article-title: Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review publication-title: Arch Pathol Lab Med doi: 10.5858/arpa.2011-0325-RS contributor: fullname: Stoecker – volume: 227 start-page: 168 year: 1997 ident: 2022061107215311500_bib24 article-title: Latent murine cytomegalovirus infection in macrophages publication-title: Virology doi: 10.1006/viro.1996.8303 contributor: fullname: Pollock – volume: 390 start-page: 174 year: 2009 ident: 2022061107215311500_bib54 article-title: Characterization of c-Kit expression and activation in KSHV-infected endothelial cells publication-title: Virology doi: 10.1016/j.virol.2009.05.011 contributor: fullname: Douglas – volume: 115 start-page: 1588 year: 2018 ident: 2022061107215311500_bib15 article-title: Mast cells promote small bowel cancer in a tumor stage-specific and cytokine-dependent manner publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1716804115 contributor: fullname: Saadalla – volume: 82 start-page: 4793 year: 2008 ident: 2022061107215311500_bib35 article-title: Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN publication-title: J Virol doi: 10.1128/JVI.01587-07 contributor: fullname: Rappocciolo – volume: 217 start-page: 304 year: 2007 ident: 2022061107215311500_bib7 article-title: Mast cells in the promotion and limitation of chronic inflammation publication-title: Immunol Rev doi: 10.1111/j.1600-065X.2007.00520.x contributor: fullname: Metz – volume: 1796 start-page: 19 year: 2009 ident: 2022061107215311500_bib13 article-title: Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation publication-title: Biochim Biophys Acta contributor: fullname: Maltby – volume: 190 start-page: 4676 year: 2013 ident: 2022061107215311500_bib12 article-title: Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling publication-title: J Immunol doi: 10.4049/jimmunol.1202096 contributor: fullname: Graham – volume: 80 start-page: 850 year: 1987 ident: 2022061107215311500_bib29 article-title: Release of tryptase together with histamine during the immediate cutaneous response to allergen publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(87)80276-2 contributor: fullname: Schwartz – volume: 13 start-page: 162 year: 2005 ident: 2022061107215311500_bib55 article-title: C-Kit (CD117) expression in AIDS-related, classic, and African endemic Kaposi sarcoma publication-title: Appl Immunohistochem Mol Morphol doi: 10.1097/00129039-200506000-00009 contributor: fullname: Pantanowitz – volume: 23 start-page: 982 year: 2005 ident: 2022061107215311500_bib56 article-title: Imatinib-induced regression of AIDS-related Kaposi's sarcoma publication-title: J Clin Oncol doi: 10.1200/JCO.2005.06.079 contributor: fullname: Koon – volume: 79 start-page: 95 year: 2006 ident: 2022061107215311500_bib44 article-title: Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells publication-title: J Leukoc Biol doi: 10.1189/jlb.0405226 contributor: fullname: Nakayama – volume: 316 start-page: 1622 year: 1987 ident: 2022061107215311500_bib48 article-title: Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis publication-title: N Engl J Med doi: 10.1056/NEJM198706253162603 contributor: fullname: Schwartz – volume-title: The Herpesviruses year: 1982 ident: 2022061107215311500_bib27 doi: 10.1007/978-1-4684-4163-5 contributor: fullname: Roizman – volume: 26 start-page: 577 year: 1999 ident: 2022061107215311500_bib3 article-title: Mast cell "densities" in vascular proliferations: a preliminary study of pyogenic granuloma, portwine stain, cavernous hemangioma, cherry angioma, Kaposi's sarcoma, and malignant hemangioendothelioma publication-title: J Dermatol doi: 10.1111/j.1346-8138.1999.tb02052.x contributor: fullname: Hagiwara – volume: 102 start-page: 3900 year: 2003 ident: 2022061107215311500_bib41 article-title: Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis publication-title: Blood doi: 10.1182/blood-2003-02-0641 contributor: fullname: Yao – volume: 120 start-page: 2042 year: 2012 ident: 2022061107215311500_bib17 article-title: Mast cells play a protumorigenic role in primary cutaneous lymphoma publication-title: Blood doi: 10.1182/blood-2012-03-415638 contributor: fullname: Rabenhorst – volume: 108 start-page: 407 year: 2002 ident: 2022061107215311500_bib39 article-title: Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells publication-title: Cell doi: 10.1016/S0092-8674(02)00628-1 contributor: fullname: Akula – volume: 132 start-page: 463 year: 2013 ident: 2022061107215311500_bib4 article-title: Human mast cells arise from a common circulating progenitor publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2013.02.011 contributor: fullname: Maaninka – volume: 22 start-page: 648 year: 2001 ident: 2022061107215311500_bib49 article-title: Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation publication-title: Trends Immunol doi: 10.1016/S1471-4906(01)02050-6 contributor: fullname: Falus – volume: 81 start-page: 2449 year: 2007 ident: 2022061107215311500_bib23 article-title: Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells publication-title: J Virol doi: 10.1128/JVI.01769-06 contributor: fullname: Punjabi – volume: 113 start-page: 124 year: 2004 ident: 2022061107215311500_bib2 article-title: Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis publication-title: J Clin Invest doi: 10.1172/JCI200417803 contributor: fullname: Grundhoff – volume: 116 start-page: 1963 year: 2006 ident: 2022061107215311500_bib22 article-title: KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice publication-title: J Clin Invest doi: 10.1172/JCI27249 contributor: fullname: Parsons – volume: 24 start-page: 1 year: 2016 ident: 2022061107215311500_bib32 article-title: The role of mast cells in histologically "normal" appendices following emergency appendectomy in pediatric patients publication-title: Ann Diagn Pathol doi: 10.1016/j.anndiagpath.2016.06.003 contributor: fullname: Yang – volume: 6 start-page: 135 year: 2005 ident: 2022061107215311500_bib5 article-title: Mast cells in the development of adaptive immune responses publication-title: Nat Immunol doi: 10.1038/ni1158 contributor: fullname: Galli – volume: 76 start-page: 8383 year: 2002 ident: 2022061107215311500_bib43 article-title: Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells publication-title: J Virol doi: 10.1128/JVI.76.16.8383-8399.2002 contributor: fullname: Moses – volume: 107 start-page: 51 year: 1995 ident: 2022061107215311500_bib51 article-title: Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor publication-title: Int Arch Allergy Immunol doi: 10.1159/000236928 contributor: fullname: Galli – volume: 78 start-page: 3601 year: 2004 ident: 2022061107215311500_bib34 article-title: Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression publication-title: J Virol doi: 10.1128/JVI.78.7.3601-3620.2004 contributor: fullname: Krishnan |
SSID | ssj0014104 |
Score | 2.400836 |
Snippet | Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on sustained... Abstract Purpose: Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS–associated herpesvirus (KSHV). KS is... Purpose: Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 5085 |
SubjectTerms | Adult Aged Aged, 80 and over Biomarkers Cytokines - metabolism Disease Susceptibility Female Herpesviridae Infections - complications Herpesviridae Infections - virology Herpesvirus 8, Human Humans Immunohistochemistry Male Mast Cells - immunology Mast Cells - metabolism Methylhistamines - metabolism Middle Aged Models, Biological Sarcoma, Kaposi - etiology Sarcoma, Kaposi - metabolism Sarcoma, Kaposi - pathology Skin - metabolism Skin - pathology Tryptases - metabolism |
Title | Mast Cell Activation and KSHV Infection in Kaposi Sarcoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30084838 https://www.proquest.com/docview/2084913969 https://pubmed.ncbi.nlm.nih.gov/PMC6191350 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBbtFpa9lL6b7QMVegtO_ZLtHINpN3SbHvZRcjOSrbCBbbJ4nUt__X4jyXayTaHtRRjbyGbm02hmNA_GPqooUwslI08IoT2sxNQbRyrwqiTVVZloKUtKcJ59T6aX8de5mPfx8ya7pFGj8tfevJL_4Sruga-UJfsPnO0mxQ1cg78YwWGMf8Xjmbxthjl53yZl26bMnAacnk9_YOnbOCsTy3gqKTyLHMD4EbmtkuZtbmRJAKiHrvxP5yaeuLYQw28aWvuw88mYkwrKG157Jxtd19plzNTYxNa9u29yfb1su3-c423d-2XPloCMPR-hNG3t_KrOBxGYgrA2C3OkndwUkFWhbfvQClabHO0AFPpbYhJaodgvv0VmXAlU9jeOwlGen3kBldC2_U62eHrz0zA1Mg0BbIGYe4Wz20cP2aMQUojE38m8i_-h-NbYpXThq5_2fvOIHbaz7Ootvxkj92Nqt5SUiyfssbMu-MRC5Sl7oFfP2OHMxU88Z2NCDCfE8B4xHIjhhBjeIYYvV9wihjvEvGCXXz5f5FPPNc_wyjgIGg-KZlUFMpNQkdMFjBNadwqjH1ZxUGKD9KsK2mEphIINHlMjgBTmrY_dUcUqjV6yg9V6pV8zHo6lr-JECmiLsapKFWc6qqKo0tgsFlIN2KglTXFja6QUxrYUWUFkLYisBchaBLgGWQfsQ0vAAtKMjqgAv_XmtghBbCpUm4wH7JUlaDdly4kBS3dI3b1AldJ3n6yWV6ZiehJgUuEf_3HON-yox_VbdtDUG_0O2maj3hvU3AEjynp2 |
link.rule.ids | 230,315,783,787,888,27936,27937 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mast+Cell+Activation+and+KSHV+Infection+in+Kaposi+Sarcoma&rft.jtitle=Clinical+cancer+research&rft.au=Ayers%2C+Leona+W&rft.au=Barbachano-Guerrero%2C+Arturo&rft.au=McAllister%2C+Shane+C&rft.au=Ritchie%2C+Julie+A&rft.date=2018-10-15&rft.eissn=1557-3265&rft.volume=24&rft.issue=20&rft.spage=5085&rft_id=info:doi/10.1158%2F1078-0432.CCR-18-0873&rft_id=info%3Apmid%2F30084838&rft.externalDocID=30084838 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0432&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0432&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0432&client=summon |